UBS Group’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-22,242
Closed -$2K 11710
2022
Q2
$2K Buy
+22,242
New +$2.19K ﹤0.01% 9763

Other funds holding CRXTW